Install
Everything Draft and the Ultimate Pick Party! See Kenny Chesney in Las Vegas Y100’s 2025 Barstool Brackets winner is… Shotgun & Charli Birthday Club Submit your community events here! Wake Up With Shotgun & Charli Farmer of the Month News From The Pack Blog Grab Your Y100 Merch! Take Our Listener Survey St. Jude Jam 20
- 490articles · 30d
- 1+ day agolatest article
- Aug 15, 2026earliest in window
- 20%with images
- 301avg words
- News 158
- Economy, Business & Finance 126
- Sports & Fitness 112
- Politics 111
- Sports 111
- Sport 101
- Finance & Business 95
- Politics2 80
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
5+ day, 16+ hour ago (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns about the prospects of similar therapies for the tough-to-treat rare disease. Dyne’s stock led declines…...
Novo scraps two more heart drug trials, further dimming growth beyond obesity
1+ week, 7+ min ago (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...